TAO Synergies TAOX
NASDAQ TAOX
$4.12 +0.11 (+2.74%)
As of: Sep 9, 2026 · 12:29 PM EDT

TAO Synergies (TAOX) Change in Account Payables (2019 - 2026)

TAO Synergies' (TAOX) quarterly Change in Account Payables came in at -$47152.0 in Q2 2026, down 122.81% on a YoY basis from $206715.0 in Q2 2025, and up 79.41% quarter-over-quarter from -$228996.0 in Q1 2026.

Analysis

TAO Synergies (TAOX) Change in Account Payables (2019 - 2026) Analysis & Trends

TAO Synergies (TAOX) has reported Change in Account Payables for 8 consecutive years, with -$47152.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Change in Account Payables fell 122.81% year-over-year to -$47152.0; the trailing twelve-month figure through Jun 2026 stood at $578279.0 (up 474.45% YoY), and the FY2025 full-year result was $858036.0, up 773.78% from the prior year.
  • Change in Account Payables advanced to -$47152.0 in Q2 2026 per TAOX's latest filing, from -$228996.0 in the prior quarter.
  • Across five years, Change in Account Payables topped out at $628754.0 in Q3 2025 and bottomed at -$895156.0 in Q1 2022.
  • Historically, Change in Account Payables has averaged -$22073.9 across 5 years, with a median of -$8107.5 in 2024.
  • The sharpest annual moves came in 2023 and 2025: Change in Account Payables slumped 211.06% in 2023, then jumped 629.46% in 2025.
  • Over 5 years, Change in Account Payables stood at $176816.0 in 2022, then soared by 30.31% to $230415.0 in 2023, then sank by 86.57% to $30937.0 in 2024, then surged by 629.46% to $225673.0 in 2025, then sank by 120.89% to -$47152.0 in 2026.
  • According to Business Quant data, Change in Account Payables over the past three periods registered -$47152.0, -$228996.0, and $225673.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Amgen 211.37 Bn 197.38 Bn 7.24 Bn -70.00 Mn
2 Gilead Sciences 181.12 Bn 177.94 Bn 6.22 Bn 18.00 Mn
3 Vertex Pharmaceuticals 132.11 Bn 124.26 Bn 2.84 Bn -66.70 Mn
4 Regeneron Pharmaceuticals 82.51 Bn 74.52 Bn 3.93 Bn -
5 Argenx Se 61.69 Bn 56.50 Bn 1.37 Bn -
6 Moderna 54.62 Bn 49.48 Bn 52.00 Mn -8.00 Mn
7 Alnylam Pharmaceuticals 34.14 Bn 30.84 Bn 992.69 Mn -
8 Biogen 31.29 Bn 30.01 Bn 1.96 Bn -
9 Roivant Sciences 30.09 Bn 30.09 Bn 1.16 Mn 7.11 Mn
10 TAO Synergies 30.79 Mn 30.79 Mn - -47,152.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -47,152.00
Mar 31, 2026 -228,996.00
Dec 31, 2025 225,673.00
Sep 30, 2025 628,754.00
Jun 30, 2025 206,715.00
Mar 31, 2025 -203,106.00
Dec 31, 2024 30,937.00
Sep 30, 2024 -188,980.00
Jun 30, 2024 236,425.00
Mar 31, 2024 -205,728.00
Dec 31, 2023 230,415.00
Sep 30, 2023 -224,929.00
Jun 30, 2023 83,246.00
Mar 31, 2023 -304,305.00
Dec 31, 2022 176,816.00
Sep 30, 2022 202,524.00
Jun 30, 2022 -120,484.00
Mar 31, 2022 -895,156.00
Dec 31, 2021 361,131.00
Sep 30, 2021 287,212.00